JP Morgan Chase’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $178M | Sell |
200,400
-25,100
| -11% | -$25.4M | 0.01% | 738 |
|
|
2025
Q4 | $242M | Buy |
225,500
+115,700
| +105% | +$111M | 0.02% | 605 |
|
|
2025
Q3 | $83.8M | Sell |
109,800
-55,200
| -33% | -$41.1M | 0.01% | 1085 |
|
|
2025
Q2 | $129M | Sell |
165,000
-217,500
| -57% | -$169M | 0.01% | 827 |
|
|
2025
Q1 | $316M | Sell |
382,500
-44,000
| -10% | -$36.6M | 0.02% | 521 |
|
|
2024
Q4 | $329M | Buy |
426,500
+66,700
| +19% | +$55.2M | 0.02% | 499 |
|
|
2024
Q3 | $319M | Buy |
359,800
+114,900
| +47% | +$103M | 0.02% | 515 |
|
|
2024
Q2 | $222M | Sell |
244,900
-51,600
| -17% | -$41.3M | 0.02% | 625 |
|
|
2024
Q1 | $231M | Buy |
296,500
+25,900
| +10% | +$18.4M | 0.02% | 608 |
|
|
2023
Q4 | $158M | Buy |
270,600
+12,700
| +5% | +$7.41M | 0.02% | 697 |
|
|
2023
Q3 | $139M | Buy |
257,900
+119,500
| +86% | +$61.6M | 0.02% | 674 |
|
|
2023
Q2 | $64.9M | Buy |
138,400
+55,300
| +67% | +$23.2M | 0.01% | 1008 |
|
|
2023
Q1 | $28.5M | Sell |
83,100
-28,900
| -26% | -$9.75M | ﹤0.01% | 1401 |
|
|
2022
Q4 | $41M | Sell |
112,000
-57,600
| -34% | -$20.4M | 0.01% | 1213 |
|
|
2022
Q3 | $54.8M | Sell |
169,600
-41,800
| -20% | -$13.2M | 0.01% | 1010 |
|
|
2022
Q2 | $68.5M | Sell |
211,400
-6,900
| -3% | -$2.07M | 0.01% | 904 |
|
|
2022
Q1 | $62.5M | Sell |
218,300
-68,500
| -24% | -$17.6M | 0.01% | 1056 |
|
|
2021
Q4 | $79.2M | Buy |
286,800
+65,300
| +29% | +$16.6M | 0.01% | 988 |
|
|
2021
Q3 | $51.2M | Buy |
221,500
+122,900
| +125% | +$30.3M | 0.01% | 1167 |
|
|
2021
Q2 | $22.6M | Buy |
98,600
+21,200
| +27% | +$4.26M | ﹤0.01% | 1730 |
|
|
2021
Q1 | $14.5M | Buy |
77,400
+77,000
| +19,250% | +$15.1M | ﹤0.01% | 2019 |
|
|
2020
Q4 | $68K | Sell |
400
-430,000
| -100% | -$64.2M | ﹤0.01% | 5086 |
|
|
2020
Q3 | $63M | Buy |
430,400
+429,300
| +39,027% | +$66.4M | 0.01% | 867 |
|
|
2020
Q2 | $181K | Sell |
1,100
-99,600
| -99% | -$15.3M | ﹤0.01% | 4311 |
|
|
2020
Q1 | $14M | Buy |
100,700
+18,000
| +22% | +$2.47M | ﹤0.01% | 1481 |
|
|
2019
Q4 | $10.9M | Sell |
82,700
-39,300
| -32% | -$4.56M | ﹤0.01% | 2049 |
|
|
2019
Q3 | $13.6M | Hold |
122,000
| – | – | ﹤0.01% | 1884 |
|
|
2019
Q2 | $13.6M | Sell |
122,000
-72,800
| -37% | -$8.57M | ﹤0.01% | 1861 |
|
|
2019
Q1 | $25.3M | Sell |
194,800
-190,000
| -49% | -$23.1M | 0.01% | 1386 |
|
|
2018
Q4 | $44.5M | Buy |
384,800
+68,000
| +21% | +$7.6M | 0.01% | 955 |
|
|
2018
Q3 | $34M | Buy |
316,800
+37,800
| +14% | +$3.78M | 0.01% | 1263 |
|
|
2018
Q2 | $23.8M | Buy |
279,000
+89,900
| +48% | +$7.38M | ﹤0.01% | 1449 |
|
|
2018
Q1 | $14.6M | Buy |
189,100
+57,500
| +44% | +$4.63M | ﹤0.01% | 1748 |
|
|
2017
Q4 | $11.1M | Buy |
131,600
+40,000
| +44% | +$3.4M | ﹤0.01% | 2037 |
|
|
2017
Q3 | $7.79M | Buy |
91,600
+88,000
| +2,444% | +$7.22M | ﹤0.01% | 2193 |
|
|
2017
Q2 | $296K | Sell |
3,600
-247
| -6% | -$20.2K | ﹤0.01% | 3890 |
|
|
2017
Q1 | $324K | Sell |
3,847
-112,800
| -97% | -$9.03M | ﹤0.01% | 3878 |
|
|
2016
Q4 | $8.58M | Buy |
116,647
+71,647
| +159% | +$5.34M | ﹤0.01% | 2032 |
|
|
2016
Q3 | $3.61M | Buy |
+45,000
| New | +$3.6M | ﹤0.01% | 2450 |
|
|
2016
Q1 | – | Sell |
-70,000
| Closed | -$5.9M | – | 4819 |
|
|
2015
Q4 | $5.9M | Hold |
70,000
| – | – | ﹤0.01% | 2117 |
|
|
2015
Q3 | $5.86M | Buy |
+70,000
| New | +$5.91M | ﹤0.01% | 2120 |
|
|
2015
Q1 | – | Sell |
-775,146
| Closed | -$53.5M | – | 4183 |
|
|
2014
Q4 | $53.5M | Buy |
775,146
+754,746
| +3,700% | +$50.9M | 0.01% | 894 |
|
|
2014
Q3 | $1.32M | Buy |
+20,400
| New | +$1.29M | ﹤0.01% | 3171 |
|
|
2014
Q1 | – | Sell |
-10,100
| Closed | -$515K | – | 3770 |
|
|
2013
Q4 | $515K | Sell |
10,100
-15,500
| -61% | -$776K | ﹤0.01% | 3477 |
|
|
2013
Q3 | $1.29M | Sell |
25,600
-6,400
| -20% | -$335K | ﹤0.01% | 3109 |
|
|
2013
Q2 | $1.57M | Buy |
+32,000
| New | +$1.74M | ﹤0.01% | 2962 |
|
Other funds holding LLY
VCM
VPM
JP Morgan Chase's LLY Position: Q1 2026 in Review
JP Morgan Chase increased its Eli Lilly (LLY) stake by 5.4% in Q1 2026, buying an estimated $710M and bringing the position to 13,698,491 shares worth $12.1B. The position accounts for 0.78% of the portfolio, ranked #18.
JP Morgan Chase first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.1B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- JP Morgan Chase held 13,698,491 shares of Eli Lilly worth $12.1B as of Q1 2026.
- JP Morgan Chase bought 700,545 Eli Lilly shares in Q1 2026, an estimated $710M.
- Eli Lilly made up 0.78% of JP Morgan Chase's portfolio in Q1 2026, its #18 holding.
- JP Morgan Chase first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Eli Lilly position peaked at $17.1B in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.